drugset / Trial / NCT02349243
Effect of Entacapone on Bodyweight Loss in Obese Population
Phase 1/2
Unknown
30 enrolled
Kaichun Wu
National Institute of Biological Sciences, Beijing · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, controlled, double blind clinical trial. The purpose of this study is to investigate the weight loss efficacy of entacapone. In this study, participants are randomly divided into entacapone and placebo groups. The percentage change in body weight, the body mass index, waist circumstance, extent of fatty liver, quantity of visceral fat, serum insulin, serum triglyceride and the adverse effects are compared between the two groups.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-09
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entacapone | Small molecule | 200 mg | Oral |